The Arg617-Arg618 cleavage site in the C-terminal domain of PC1 plays a major role in the processing and targeting of the enzyme within the regulated secretory pathway.

PubWeight™: 0.79‹?›

🔗 View Article (PMID 12787078)

Published in J Neurochem on June 01, 2003

Authors

Natacha Bernard1, Patrick Kitabgi, Carole Rovere-Jovene

Author Affiliations

1: Institut de Pharmacologie Molèculaire et Cellulaire, Centre National de la Recherche Scientifique, UMR 6097, Valbonne, France.

Articles by these authors

Chemokines: a new class of neuromodulator? Nat Rev Neurosci (2007) 1.76

Neuroanatomical distribution of CXCR4 in adult rat brain and its localization in cholinergic and dopaminergic neurons. Eur J Neurosci (2002) 1.52

Spinal CCL2 pronociceptive action is no longer effective in CCR2 receptor antagonist-treated rats. J Neurochem (2008) 1.37

Highly regionalized neuronal expression of monocyte chemoattractant protein-1 (MCP-1/CCL2) in rat brain: evidence for its colocalization with neurotransmitters and neuropeptides. J Comp Neurol (2005) 1.32

Constitutive neuronal expression of CCR2 chemokine receptor and its colocalization with neurotransmitters in normal rat brain: functional effect of MCP-1/CCL2 on calcium mobilization in primary cultured neurons. J Comp Neurol (2005) 1.30

Highly regionalized distribution of stromal cell-derived factor-1/CXCL12 in adult rat brain: constitutive expression in cholinergic, dopaminergic and vasopressinergic neurons. Eur J Neurosci (2003) 1.30

The chemokine SDF-1 differentially regulates axonal elongation and branching in hippocampal neurons. J Cell Sci (2005) 1.26

Constitutive expression of CCR2 chemokine receptor and inhibition by MCP-1/CCL2 of GABA-induced currents in spinal cord neurones. J Neurochem (2005) 1.26

CCL2 released from neuronal synaptic vesicles in the spinal cord is a major mediator of local inflammation and pain after peripheral nerve injury. J Neurosci (2011) 1.17

Estradiol inhibits ongoing autoimmune neuroinflammation and NFkappaB-dependent CCL2 expression in reactive astrocytes. Proc Natl Acad Sci U S A (2010) 1.09

Altered processing of the neurotensin/neuromedin N precursor in PC2 knock down mice: a biochemical and immunohistochemical study. J Neurochem (2002) 1.08

Constitutive activation of the neurotensin receptor 1 by mutation of Phe(358) in Helix seven. Br J Pharmacol (2002) 0.99

The chemokine SDF-1/CXCL12 modulates the firing pattern of vasopressin neurons and counteracts induced vasopressin release through CXCR4. Proc Natl Acad Sci U S A (2006) 0.97

Chemokines and brain functions. Curr Drug Targets Inflamm Allergy (2005) 0.94

Cellular and subcellular localization of CXCL12 and CXCR4 in rat nociceptive structures: physiological relevance. Eur J Neurosci (2012) 0.93

Appetite-boosting property of pro-melanin-concentrating hormone(131-165) (neuropeptide-glutamic acid-isoleucine) is associated with proteolytic resistance. J Pharmacol Exp Ther (2002) 0.84

NOV/CCN3 attenuates inflammatory pain through regulation of matrix metalloproteinases-2 and -9. J Neuroinflammation (2012) 0.84

Dendrite-selective redistribution of the chemokine receptor CXCR4 following agonist stimulation. Mol Cell Neurosci (2006) 0.84

Production of recombinant large proneurotensin/neuromedin N-derived peptides and characterization of their binding and biological activity. Biochem Biophys Res Commun (2002) 0.79

[Chemokines as new actors in the dopaminergic system]. Biol Aujourdhui (2011) 0.79

Cellular and subcellular evidence for neuronal interaction between the chemokine stromal cell-derived factor-1/CXCL 12 and vasopressin: regulation in the hypothalamo-neurohypophysial system of the Brattleboro rats. Endocrinology (2007) 0.77

Implication of CCR2 chemokine receptor in cocaine-induced sensitization. J Mol Neurosci (2011) 0.77

Insertion of dibasic residues directs a constitutive protein to the regulated secretory pathway. Biochem Biophys Res Commun (2002) 0.77